Lynn Abruzzo

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Risk stratification is important to identify patients with acute myelogenous leukemia (AML) who might benefit from allogeneic hematopoietic stem cell transplantation (allo-HSCT) in first complete remission. We retrospectively studied 150 patients with AML and diagnostic cytogenetic abnormalities who underwent myeloablative allo-HSCT while in first complete(More)
  • 1